Patents Assigned to BLINK BIOMEDICAL SAS
  • CD96-BINDING AGENTS AS IMMUNOMODULATORS
    Publication number: 20230192845
    Abstract: Provided is a CD96-binding agent, wherein the agent is capable of stimulating activation and/or proliferation of T cells upon binding to CD96. Also provided are isolated nucleic acids and cells that produce the agent and uses thereof.
    Type: Application
    Filed: August 10, 2018
    Publication date: June 22, 2023
    Applicants: BLINK BIOMEDICAL SAS, TALIX THERAPEUTICS NV
    Inventors: Florence Renart-Depontieu, Sachiko Takami, Germain Margall-Ducos, Nicola Beltraminel-Li, Pierre Garrone, Anne Rogel, Aymen Al-Shamkhani, Xavier Preville